Additional file 1: Table S1. of Method for estimating high sdLDL-C by measuring triglyceride and apolipoprotein B levels

Alternative LDL window in healthy subjects. Table S2. Alternative LDL window in patients with type 2 diabetes. Table S3. Alternative LDL window in 528 patients with CAD including diabetes. (DOCX 29 kb

lassie

molassesI know 'twas some feed now - lassie on praties!YesDNE-cit J. D. A. WIDDOWSONJAN 1973Used I and SupUsed I and SupNot use

Long-term subfoveal choroidal thickness changes following half-dose photodynamic therapy (PDT) in eyes with chronic central serous chorioretinopathy.

<p>After PDT, baseline subfoveal choroidal thickness significantly decreased at each visit in the successful group and at 1, 3, 24, and 36 months in the unsuccessful group. All values are presented as mean ± standard error of the mean. *<i>P</i> < 0.05, **<i>P</i> < 0.01, ***<i>P</i> < 0.001.</p

Kaplan–Meier survival plot showing the proportion of eyes without subretinal fluid after initial half-dose photodynamic therapy.

<p>Recurrence continued to occur during the 5-year follow-up period.</p

Summary of findings of the three highly reflective bands at the outer retina obtained by SD-OCT at the initial visit and six months later.

<p>These three lines were divided into three types; “continuous”, “discontinuous” and “absent”. ELM, external limiting membrane. EZ, ellipsoid zone. IDZ, interdigitation zone.</p

Long-term visual acuity changes following half-dose photodynamic therapy in eyes with chronic central serous chorioretinopathy.

<p>Baseline best-corrected visual acuity (BCVA) significantly improved after 3, 6, 12, 24, and 36 months in the successful group and at 24 and 36 months in the unsuccessful group. All values are presented as mean ± standard error of the mean. *<i>P</i> < 0.05.</p

Comparison of baseline clinical characteristics according to success of half-dose PDT.

<p>Comparison of baseline clinical characteristics according to success of half-dose PDT.</p

Inclusion and exclusion criteria of the patients recruited in the study.

<p>Inclusion and exclusion criteria of the patients recruited in the study.</p

Static visual field and spectral-domain optical coherence tomography (SD-OCT) results of the right eye of Case 1 at the initial visit (A–C) and six months after the initial visit (D–F).

<p>A: Deviation plot obtained with the Humphrey 30-2 program at the initial visit. B: Horizontal SD-OCT image through the fovea at the initial visit. C: Magnified view of the area outlined by dashed yellow line box in B. D: Deviation plot obtained with the Humphrey 30-2 program at six months after the initial visit. E: Horizontal SD-OCT image through the fovea at six months after the initial visit. F: Magnified view of the area outlined by dashed yellow line box in the image of B. ELM, external limiting membrane. EZ, ellipsoid zone. IDZ, interdigitation zone. Several column-shaped highly reflective materials are seen at the outer retinal area of visual field defect at the initial visit (red arrows).</p

Static visual field and spectral-domain optical coherence tomographic (SD-OCT) results in the right eye of Case 3 at the initial visit (A–C) and six months after the initial visit (D–F).

<p>A: Deviation plot obtained by the Humphrey 30-2 program at the initial visit. B: Horizontal SD-OCT image through the fovea at the initial visit. C: Magnified view of the area outlined by dashed yellow line box in the image of B. D: Deviation plot obtained by the Humphrey 30-2 program at six months after the initial visit. E: Horizontal SD-OCT image through the fovea at six months after the initial visit. F: Magnified view of the area outlined by dashed yellow line box in the image of E. ELM, external limiting membrane. EZ, ellipsoid zone. IDZ, interdigitation zone.</p